Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease

被引:35
作者
Zheng, Dekai [1 ,2 ]
Liao, Huimin [3 ]
Chen, Shuze [1 ,2 ]
Liu, Xiuying [1 ]
Mao, Chuyin [3 ]
Zhang, Cangui [1 ]
Meng, Min [3 ]
Wang, Zhi [1 ]
Wang, Ying [1 ]
Jiang, Qinrui [1 ]
Xue, Yaoming [3 ]
Zhou, Lin [3 ]
Chen, Ye [1 ,2 ]
机构
[1] Southern Med Univ, Guangdong Prov Key Lab Gastroenterol, State Key Lab Organ Failure Res, Dept Gastroenterol,Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Shenzhen Hosp, Integrat Clin Ctr Microecol, Dept Gastroenterol, Guangzhou, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
intestinal barrier; leaky gut; bacterial translocation; Graves' disease; lipopolysaccharide; intestinal fatty acid-binding protein; quality of Life; INTESTINAL BARRIER; HYPERTHYROIDISM; ZONULIN; PERMEABILITY; MICROBIOME; SYSTEM;
D O I
10.3389/fendo.2021.796212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundA growing number of studies have found dysbiosis of the intestinal microbiota in patients with Graves' disease (GD). The intestinal epithelial barrier serves as the first line of defense, protecting the immune system from excessive stimulation of microbiota and toxins. Most autoimmune diseases are associated with a gut barrier dysfunction (leaky gut) which allows bacterial translocation. However, to date, potential correlations between intestinal barrier dysfunction and GD have not been explored. MethodsSerum lipopolysaccharide (LPS), intestinal fatty acid-binding protein (I-FABP), zonulin, D-lactate, and diamine oxidase (DAO) were measured to assess barrier integrity in 91 patients with GD (61 initial GD and 30 euthyroid GD) and 44 healthy controls. The quality of life (QOL) of patients with GD was assessed using the thyroid-specific patient-reported outcome (ThyPRO-39) questionnaire. ResultsThe serum levels of LPS, I-FABP, zonulin, and D-lactate were significantly higher in patients with initial GD than in healthy controls. Logistic regression analysis revealed that zonulin and D-lactate were independently associated with risk for GD and circulating zonulin could effectively distinguish patients with initial GD from healthy controls. Correlation analyses showed that I-FABP, LPS, and D-lactate were positively associated with FT4 and negatively associated with TSH. In addition, circulating LPS, zonulin, and D-lactate levels were all independent predictors of TRAb levels. Moreover, higher circulating LPS levels in patients with GD were associated with more severe hyperthyroidism (higher concentrations of FT3, FT4, and TRAb and lower TSH concentrations) and worse scores of hyperthyroid and eye symptoms. ConclusionPatients with initial GD show a disrupted intestinal barrier, characterized by elevated levels of leaky gut biomarkers. Increased intestinal permeability and bacterial translocation were associated with TRAb levels and hyperthyroidism in GD. Further research is required to elucidate the underlying mechanisms.
引用
收藏
页数:10
相关论文
共 39 条
[1]   Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy [J].
Antonelli, Alessandro ;
Fallahi, Poupak ;
Elia, Giusy ;
Ragusa, Francesca ;
Paparo, Sabrina Rosaria ;
Ruffilli, Ilaria ;
Patrizio, Armando ;
Gonnella, Debora ;
Giusti, Claudia ;
Virili, Camilla ;
Centanni, Marco ;
Shoenfeld, Yehuda ;
Ferrari, Silvia Martina .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 34 (01)
[2]   Molecular mimicry and autoimmune thyroid disease [J].
Benvenga, Salvatore ;
Guarneri, Fabrizio .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (04) :485-498
[3]   Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity [J].
Camara-Lemarroy, Carlos R. ;
Silva, Claudia ;
Greenfield, Jamie ;
Liu, Wei-Qiao ;
Metz, Luanne M. ;
Yong, V. Wee .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (11) :1340-1350
[4]   The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics [J].
Camara-Lemarroy, Carlos R. ;
Metz, Luanne ;
Meddings, Jonathan B. ;
Sharkey, Keith A. ;
Yong, V. Wee .
BRAIN, 2018, 141 :1900-1916
[5]   The immune system and the gut microbiota: friends or foes? [J].
Cerf-Bensussan, Nadine ;
Gaboriau-Routhiau, Valerie .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (10) :735-744
[6]   Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders [J].
Chopyk, Daniel M. ;
Grakoui, Arash .
GASTROENTEROLOGY, 2020, 159 (03) :849-863
[7]   Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction [J].
Chow, JC ;
Young, DW ;
Golenbock, DT ;
Christ, WJ ;
Gusovsky, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10689-10692
[8]   Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset [J].
Costa, Frederico R. C. ;
Francozo, Marcela C. S. ;
de Oliveira, Gabriela G. ;
Ignacio, Aline ;
Castoldi, Angela ;
Zamboni, Dario S. ;
Ramos, Simone G. ;
Camara, Niels O. ;
de Zoete, Marcel R. ;
Palm, Noah W. ;
Flavell, Richard A. ;
Silva, Joao S. ;
Carlos, Daniela .
JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (07) :1223-1239
[9]   Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study [J].
Cramon, Per ;
Winther, Kristian Hillert ;
Watt, Torquil ;
Bonnema, Steen Joop ;
Bjorner, Jakob Bue ;
Ekholm, Ola ;
Groenvold, Mogens ;
Hegedus, Laszlo ;
Feldt-Rasmussen, Ulla ;
Rasmussen, Ase Krogh .
THYROID, 2016, 26 (08) :1010-1018
[10]   Graves' disease [J].
Davies, Terry F. ;
Andersen, Stig ;
Latif, Rauf ;
Nagayama, Yuji ;
Barbesino, Giuseppe ;
Brito, Maria ;
Eckstein, Anja K. ;
Stagnaro-Green, Alex ;
Kahaly, George J. .
NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)